DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts
Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1). Emerging evidence suggests that plasma ADMA accumulation, DDAH1 activity/expression reduction, and microRNA-21 (miR-21) upregulation are linked t...
Gespeichert in:
Veröffentlicht in: | Free radical biology & medicine 2016-03, Vol.92, p.50-60 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 60 |
---|---|
container_issue | |
container_start_page | 50 |
container_title | Free radical biology & medicine |
container_volume | 92 |
creator | Zhao, Chenyang Li, Tianhe Han, Bingxing Yue, Wenhui Shi, Linlin Wang, Hongyun Guo, Yuting Lu, Zhongbing |
description | Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1). Emerging evidence suggests that plasma ADMA accumulation, DDAH1 activity/expression reduction, and microRNA-21 (miR-21) upregulation are linked to disease pathology, but the mechanisms remain largely unknown. In the present study, we assessed the potential role of the ADMA–DDAH1–miR-21 pathway in the regulation of the cellular redox state and apoptosis using wild-type (WT) and DDAH1-knockout (KO) immortalized mouse embryonic fibroblasts (MEFs). DDAH1 deficiency significantly increased ADMA levels, enhanced cellular oxidative stress, and rendered cells more vulnerable to apoptosis induced by tert-butyl hydroperoxide (tBHP) or A23187. However, treatment with exogenous ADMA (1–80μM) for 24h or for a prolonged period (10μM, 10 passages) in WT MEFs had no marked effect on intracellular reactive oxygen species (ROS) and apoptosis sensitivity. Interestingly, miR-21 expression was significantly increased, by 4 fold, in DDAH1−/− MEFs, and the induction of miR-21 by DDAH1 deficiency was dependent on oxidative stress and NF-κB activation. Inhibition of DDAH1 activity by PD 404182 also increased miR-21 expression. Furthermore, inhibition of miR-21 with a lentiviral vector in DDAH1−/− MEFs significantly upregulated SOD2 expression and the attenuated oxidative stress and apoptosis induced by tBHP or A23187. Taken together, our results suggest that DDAH1 not only acts as an enzyme degrading ADMA but also controls cellular oxidative stress and apoptosis via a miR-21-dependent pathway.
[Display omitted]
•DDAH1 deficiency exacerbates tBHP- and A23187-induced viability loss and apoptosis.•DDAH1 deficiency increases oxidative stress through downregulation of SOD2.•MiR-21 was upregulated in Ddah1−/− MEFs.•NF-κB activation contributes to miR-21 expression in Ddah1−/− MEFs.•Inhibition of miR-21 ameliorates apoptosis and oxidative stress in Ddah1−/− MEFs. |
doi_str_mv | 10.1016/j.freeradbiomed.2016.01.015 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1768554433</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0891584916000290</els_id><sourcerecordid>1768554433</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-39d476635bb7f1a0d60c0313af7838a579449ffcd4d07d4c21f4ac374f59d00b3</originalsourceid><addsrcrecordid>eNqNUU1rHDEMNaEh2ab9C8XQSy-zsdf2fNBTSNKmEAiE9mw0tky9zIyntnfb_Qn91_F0k0NvAYFAetLT0yPkI2drznh9uV27iBjB9j6MaNebUlwzXkKdkBVvG1FJ1dVvyIq1Ha9UK7tz8jalLWNMKtGekfNN3bJaKb4if29uru44tei88TiZA51jGEPGRP2UIxgcht0AkYY_3kL2e6QpR0yJwmTp0qUwhzmH5BPde6BAR_9YbXhlccbJ4pTpDPnnbziUhXQMu4QUxz4ewuQNdb6PoR8g5fSOnDoYEr5_zhfkx5fb79d31f3D12_XV_eVKcfnSnRWNnUtVN83jgOzNTNMcAGuaUULqumk7JwzVlrWWGk23EkwopFOdZaxXlyQT8e9ReivHaasR58WITBhuU7zpm6VklKIAv18hJoYUoro9Bz9CPGgOdOLF3qr__NCL15oxkuoMv3hmWjXL72X2ZfnF8DtEYBF7t5j1OmfB2h9RJO1Df5VRE9x8aTI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1768554433</pqid></control><display><type>article</type><title>DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zhao, Chenyang ; Li, Tianhe ; Han, Bingxing ; Yue, Wenhui ; Shi, Linlin ; Wang, Hongyun ; Guo, Yuting ; Lu, Zhongbing</creator><creatorcontrib>Zhao, Chenyang ; Li, Tianhe ; Han, Bingxing ; Yue, Wenhui ; Shi, Linlin ; Wang, Hongyun ; Guo, Yuting ; Lu, Zhongbing</creatorcontrib><description>Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1). Emerging evidence suggests that plasma ADMA accumulation, DDAH1 activity/expression reduction, and microRNA-21 (miR-21) upregulation are linked to disease pathology, but the mechanisms remain largely unknown. In the present study, we assessed the potential role of the ADMA–DDAH1–miR-21 pathway in the regulation of the cellular redox state and apoptosis using wild-type (WT) and DDAH1-knockout (KO) immortalized mouse embryonic fibroblasts (MEFs). DDAH1 deficiency significantly increased ADMA levels, enhanced cellular oxidative stress, and rendered cells more vulnerable to apoptosis induced by tert-butyl hydroperoxide (tBHP) or A23187. However, treatment with exogenous ADMA (1–80μM) for 24h or for a prolonged period (10μM, 10 passages) in WT MEFs had no marked effect on intracellular reactive oxygen species (ROS) and apoptosis sensitivity. Interestingly, miR-21 expression was significantly increased, by 4 fold, in DDAH1−/− MEFs, and the induction of miR-21 by DDAH1 deficiency was dependent on oxidative stress and NF-κB activation. Inhibition of DDAH1 activity by PD 404182 also increased miR-21 expression. Furthermore, inhibition of miR-21 with a lentiviral vector in DDAH1−/− MEFs significantly upregulated SOD2 expression and the attenuated oxidative stress and apoptosis induced by tBHP or A23187. Taken together, our results suggest that DDAH1 not only acts as an enzyme degrading ADMA but also controls cellular oxidative stress and apoptosis via a miR-21-dependent pathway.
[Display omitted]
•DDAH1 deficiency exacerbates tBHP- and A23187-induced viability loss and apoptosis.•DDAH1 deficiency increases oxidative stress through downregulation of SOD2.•MiR-21 was upregulated in Ddah1−/− MEFs.•NF-κB activation contributes to miR-21 expression in Ddah1−/− MEFs.•Inhibition of miR-21 ameliorates apoptosis and oxidative stress in Ddah1−/− MEFs.</description><identifier>ISSN: 0891-5849</identifier><identifier>EISSN: 1873-4596</identifier><identifier>DOI: 10.1016/j.freeradbiomed.2016.01.015</identifier><identifier>PMID: 26806551</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>ADMA ; Amidohydrolases - antagonists & inhibitors ; Amidohydrolases - genetics ; Amidohydrolases - metabolism ; Animals ; Apoptosis - drug effects ; Arginine - administration & dosage ; Arginine - analogs & derivatives ; DDAH1 ; Embryo, Mammalian - drug effects ; Embryo, Mammalian - metabolism ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Enzyme Inhibitors - administration & dosage ; Fibroblasts - drug effects ; Fibroblasts - metabolism ; Gene Expression Regulation - drug effects ; Mice ; MicroRNAs - genetics ; MicroRNAs - metabolism ; miRNA ; NF-kappa B - genetics ; Nitric Oxide - genetics ; Nitric Oxide Synthase Type III - antagonists & inhibitors ; Nitric Oxide Synthase Type III - genetics ; Oxidative stress ; Oxidative Stress - genetics ; Signal Transduction - drug effects ; SOD2 ; Superoxide Dismutase - biosynthesis</subject><ispartof>Free radical biology & medicine, 2016-03, Vol.92, p.50-60</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-39d476635bb7f1a0d60c0313af7838a579449ffcd4d07d4c21f4ac374f59d00b3</citedby><cites>FETCH-LOGICAL-c453t-39d476635bb7f1a0d60c0313af7838a579449ffcd4d07d4c21f4ac374f59d00b3</cites><orcidid>0000-0002-2717-4698</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0891584916000290$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26806551$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Chenyang</creatorcontrib><creatorcontrib>Li, Tianhe</creatorcontrib><creatorcontrib>Han, Bingxing</creatorcontrib><creatorcontrib>Yue, Wenhui</creatorcontrib><creatorcontrib>Shi, Linlin</creatorcontrib><creatorcontrib>Wang, Hongyun</creatorcontrib><creatorcontrib>Guo, Yuting</creatorcontrib><creatorcontrib>Lu, Zhongbing</creatorcontrib><title>DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts</title><title>Free radical biology & medicine</title><addtitle>Free Radic Biol Med</addtitle><description>Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1). Emerging evidence suggests that plasma ADMA accumulation, DDAH1 activity/expression reduction, and microRNA-21 (miR-21) upregulation are linked to disease pathology, but the mechanisms remain largely unknown. In the present study, we assessed the potential role of the ADMA–DDAH1–miR-21 pathway in the regulation of the cellular redox state and apoptosis using wild-type (WT) and DDAH1-knockout (KO) immortalized mouse embryonic fibroblasts (MEFs). DDAH1 deficiency significantly increased ADMA levels, enhanced cellular oxidative stress, and rendered cells more vulnerable to apoptosis induced by tert-butyl hydroperoxide (tBHP) or A23187. However, treatment with exogenous ADMA (1–80μM) for 24h or for a prolonged period (10μM, 10 passages) in WT MEFs had no marked effect on intracellular reactive oxygen species (ROS) and apoptosis sensitivity. Interestingly, miR-21 expression was significantly increased, by 4 fold, in DDAH1−/− MEFs, and the induction of miR-21 by DDAH1 deficiency was dependent on oxidative stress and NF-κB activation. Inhibition of DDAH1 activity by PD 404182 also increased miR-21 expression. Furthermore, inhibition of miR-21 with a lentiviral vector in DDAH1−/− MEFs significantly upregulated SOD2 expression and the attenuated oxidative stress and apoptosis induced by tBHP or A23187. Taken together, our results suggest that DDAH1 not only acts as an enzyme degrading ADMA but also controls cellular oxidative stress and apoptosis via a miR-21-dependent pathway.
[Display omitted]
•DDAH1 deficiency exacerbates tBHP- and A23187-induced viability loss and apoptosis.•DDAH1 deficiency increases oxidative stress through downregulation of SOD2.•MiR-21 was upregulated in Ddah1−/− MEFs.•NF-κB activation contributes to miR-21 expression in Ddah1−/− MEFs.•Inhibition of miR-21 ameliorates apoptosis and oxidative stress in Ddah1−/− MEFs.</description><subject>ADMA</subject><subject>Amidohydrolases - antagonists & inhibitors</subject><subject>Amidohydrolases - genetics</subject><subject>Amidohydrolases - metabolism</subject><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Arginine - administration & dosage</subject><subject>Arginine - analogs & derivatives</subject><subject>DDAH1</subject><subject>Embryo, Mammalian - drug effects</subject><subject>Embryo, Mammalian - metabolism</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Enzyme Inhibitors - administration & dosage</subject><subject>Fibroblasts - drug effects</subject><subject>Fibroblasts - metabolism</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Mice</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>miRNA</subject><subject>NF-kappa B - genetics</subject><subject>Nitric Oxide - genetics</subject><subject>Nitric Oxide Synthase Type III - antagonists & inhibitors</subject><subject>Nitric Oxide Synthase Type III - genetics</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - genetics</subject><subject>Signal Transduction - drug effects</subject><subject>SOD2</subject><subject>Superoxide Dismutase - biosynthesis</subject><issn>0891-5849</issn><issn>1873-4596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUU1rHDEMNaEh2ab9C8XQSy-zsdf2fNBTSNKmEAiE9mw0tky9zIyntnfb_Qn91_F0k0NvAYFAetLT0yPkI2drznh9uV27iBjB9j6MaNebUlwzXkKdkBVvG1FJ1dVvyIq1Ha9UK7tz8jalLWNMKtGekfNN3bJaKb4if29uru44tei88TiZA51jGEPGRP2UIxgcht0AkYY_3kL2e6QpR0yJwmTp0qUwhzmH5BPde6BAR_9YbXhlccbJ4pTpDPnnbziUhXQMu4QUxz4ewuQNdb6PoR8g5fSOnDoYEr5_zhfkx5fb79d31f3D12_XV_eVKcfnSnRWNnUtVN83jgOzNTNMcAGuaUULqumk7JwzVlrWWGk23EkwopFOdZaxXlyQT8e9ReivHaasR58WITBhuU7zpm6VklKIAv18hJoYUoro9Bz9CPGgOdOLF3qr__NCL15oxkuoMv3hmWjXL72X2ZfnF8DtEYBF7t5j1OmfB2h9RJO1Df5VRE9x8aTI</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Zhao, Chenyang</creator><creator>Li, Tianhe</creator><creator>Han, Bingxing</creator><creator>Yue, Wenhui</creator><creator>Shi, Linlin</creator><creator>Wang, Hongyun</creator><creator>Guo, Yuting</creator><creator>Lu, Zhongbing</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2717-4698</orcidid></search><sort><creationdate>201603</creationdate><title>DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts</title><author>Zhao, Chenyang ; Li, Tianhe ; Han, Bingxing ; Yue, Wenhui ; Shi, Linlin ; Wang, Hongyun ; Guo, Yuting ; Lu, Zhongbing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-39d476635bb7f1a0d60c0313af7838a579449ffcd4d07d4c21f4ac374f59d00b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>ADMA</topic><topic>Amidohydrolases - antagonists & inhibitors</topic><topic>Amidohydrolases - genetics</topic><topic>Amidohydrolases - metabolism</topic><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Arginine - administration & dosage</topic><topic>Arginine - analogs & derivatives</topic><topic>DDAH1</topic><topic>Embryo, Mammalian - drug effects</topic><topic>Embryo, Mammalian - metabolism</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Enzyme Inhibitors - administration & dosage</topic><topic>Fibroblasts - drug effects</topic><topic>Fibroblasts - metabolism</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Mice</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>miRNA</topic><topic>NF-kappa B - genetics</topic><topic>Nitric Oxide - genetics</topic><topic>Nitric Oxide Synthase Type III - antagonists & inhibitors</topic><topic>Nitric Oxide Synthase Type III - genetics</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - genetics</topic><topic>Signal Transduction - drug effects</topic><topic>SOD2</topic><topic>Superoxide Dismutase - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Chenyang</creatorcontrib><creatorcontrib>Li, Tianhe</creatorcontrib><creatorcontrib>Han, Bingxing</creatorcontrib><creatorcontrib>Yue, Wenhui</creatorcontrib><creatorcontrib>Shi, Linlin</creatorcontrib><creatorcontrib>Wang, Hongyun</creatorcontrib><creatorcontrib>Guo, Yuting</creatorcontrib><creatorcontrib>Lu, Zhongbing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Free radical biology & medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Chenyang</au><au>Li, Tianhe</au><au>Han, Bingxing</au><au>Yue, Wenhui</au><au>Shi, Linlin</au><au>Wang, Hongyun</au><au>Guo, Yuting</au><au>Lu, Zhongbing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts</atitle><jtitle>Free radical biology & medicine</jtitle><addtitle>Free Radic Biol Med</addtitle><date>2016-03</date><risdate>2016</risdate><volume>92</volume><spage>50</spage><epage>60</epage><pages>50-60</pages><issn>0891-5849</issn><eissn>1873-4596</eissn><abstract>Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1). Emerging evidence suggests that plasma ADMA accumulation, DDAH1 activity/expression reduction, and microRNA-21 (miR-21) upregulation are linked to disease pathology, but the mechanisms remain largely unknown. In the present study, we assessed the potential role of the ADMA–DDAH1–miR-21 pathway in the regulation of the cellular redox state and apoptosis using wild-type (WT) and DDAH1-knockout (KO) immortalized mouse embryonic fibroblasts (MEFs). DDAH1 deficiency significantly increased ADMA levels, enhanced cellular oxidative stress, and rendered cells more vulnerable to apoptosis induced by tert-butyl hydroperoxide (tBHP) or A23187. However, treatment with exogenous ADMA (1–80μM) for 24h or for a prolonged period (10μM, 10 passages) in WT MEFs had no marked effect on intracellular reactive oxygen species (ROS) and apoptosis sensitivity. Interestingly, miR-21 expression was significantly increased, by 4 fold, in DDAH1−/− MEFs, and the induction of miR-21 by DDAH1 deficiency was dependent on oxidative stress and NF-κB activation. Inhibition of DDAH1 activity by PD 404182 also increased miR-21 expression. Furthermore, inhibition of miR-21 with a lentiviral vector in DDAH1−/− MEFs significantly upregulated SOD2 expression and the attenuated oxidative stress and apoptosis induced by tBHP or A23187. Taken together, our results suggest that DDAH1 not only acts as an enzyme degrading ADMA but also controls cellular oxidative stress and apoptosis via a miR-21-dependent pathway.
[Display omitted]
•DDAH1 deficiency exacerbates tBHP- and A23187-induced viability loss and apoptosis.•DDAH1 deficiency increases oxidative stress through downregulation of SOD2.•MiR-21 was upregulated in Ddah1−/− MEFs.•NF-κB activation contributes to miR-21 expression in Ddah1−/− MEFs.•Inhibition of miR-21 ameliorates apoptosis and oxidative stress in Ddah1−/− MEFs.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26806551</pmid><doi>10.1016/j.freeradbiomed.2016.01.015</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-2717-4698</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0891-5849 |
ispartof | Free radical biology & medicine, 2016-03, Vol.92, p.50-60 |
issn | 0891-5849 1873-4596 |
language | eng |
recordid | cdi_proquest_miscellaneous_1768554433 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | ADMA Amidohydrolases - antagonists & inhibitors Amidohydrolases - genetics Amidohydrolases - metabolism Animals Apoptosis - drug effects Arginine - administration & dosage Arginine - analogs & derivatives DDAH1 Embryo, Mammalian - drug effects Embryo, Mammalian - metabolism Endothelial Cells - drug effects Endothelial Cells - metabolism Enzyme Inhibitors - administration & dosage Fibroblasts - drug effects Fibroblasts - metabolism Gene Expression Regulation - drug effects Mice MicroRNAs - genetics MicroRNAs - metabolism miRNA NF-kappa B - genetics Nitric Oxide - genetics Nitric Oxide Synthase Type III - antagonists & inhibitors Nitric Oxide Synthase Type III - genetics Oxidative stress Oxidative Stress - genetics Signal Transduction - drug effects SOD2 Superoxide Dismutase - biosynthesis |
title | DDAH1 deficiency promotes intracellular oxidative stress and cell apoptosis via a miR-21-dependent pathway in mouse embryonic fibroblasts |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T16%3A38%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DDAH1%20deficiency%20promotes%20intracellular%20oxidative%20stress%20and%20cell%20apoptosis%20via%20a%20miR-21-dependent%20pathway%20in%20mouse%20embryonic%20fibroblasts&rft.jtitle=Free%20radical%20biology%20&%20medicine&rft.au=Zhao,%20Chenyang&rft.date=2016-03&rft.volume=92&rft.spage=50&rft.epage=60&rft.pages=50-60&rft.issn=0891-5849&rft.eissn=1873-4596&rft_id=info:doi/10.1016/j.freeradbiomed.2016.01.015&rft_dat=%3Cproquest_cross%3E1768554433%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1768554433&rft_id=info:pmid/26806551&rft_els_id=S0891584916000290&rfr_iscdi=true |